Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 5 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               63.88               75.02           269.00    
                   (-14.8 pct)         (+24.5 pct)      (-4.6 pct)  
  Operating            2.68                9.39            14.50    
                   (-71.5 pct)         (+12.8 pct)      (-27.4 pct) 
  Recurring            4.03               11.12            18.50    
                   (-63.7 pct)         (+45.3 pct)      (-28.7 pct) 
  Net                  1.18                6.06            10.50    
                   (-80.5 pct)         (-44.9 pct)      (-21.1 pct) 
  EPS               14.78 yen           75.98 yen       131.45 yen  
  EPS Diluted       14.75 yen           75.89 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news